Results 231 to 240 of about 177,862 (267)
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri +20 more
wiley +1 more source
Optogenetic-induced α-synuclein accumulation reveals early synaptic dysfunction in experimental models of Parkinson's disease. [PDF]
Rodriguez-Aller R +6 more
europepmc +1 more source
One-Carbon Metabolism and Midbrain Dopaminergic Cells in Lesch-Nyhan Disease. [PDF]
Alsuwaidi S, Ernst C.
europepmc +1 more source
Metformin Restores Mitochondrial Function and Neurogenesis in POLG Patient-Derived Brain Organoids. [PDF]
Zhang Z +6 more
europepmc +1 more source
Farnesol, a Dietary Sesquiterpene, Attenuates Rotenone-Induced Dopaminergic Neurodegeneration by Inhibiting Oxidative Stress, Inflammation, and Apoptosis via Mediation of Cell Signaling Pathways in Rats. [PDF]
Bader Eddin L +7 more
europepmc +1 more source
Another Microlesion Effect after STN‐DBS for Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Atsushi Umemura +3 more
wiley +1 more source

